Monday, June 15, 2026

SOCIALISM’S PARADOX: North Korea’s Economy Is Growing Stronger By Embracing Its Own Death

North Korea's economy is shifting to a hybrid model, blending planned and market elements, influenced by sanctions and COVID-19.

KRW Weakens as Hotter U.S. Inflation and Rising Oil Prices Deepen Risk-Off Mood

Global financial markets face risk-off sentiment as U.S. inflation data raises concerns over prolonged high interest rates and oil prices.

North Korea Test-Fires New Surface-To-Air Missile Escalating Global Tension Through High-Altitude Interception Capability

North Korea tested a new anti-aircraft missile system, seen as a counter to the U.S. THAAD, with Kim Jong Un overseeing the launch.

Tag: R&D

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

SK Nexilis to Showcase 4-Micrometer Ultra-Wide Copper Foil at InterBattery 2026

SK Nexilis will showcase innovative copper foil technology at InterBattery 2026, enhancing productivity for battery manufacturers.

Future of EV Batteries—Dongwha Electrolyte’s R&D Roadmap Revealed

Dongwha Electrolyte will present its R&D roadmap and strategies for global battery regulations at InterBattery 2026 in Seoul.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

South Korea’s Auto Industry Is Being Hollowed Out—And No One’s Sounding the Alarm

South Korea's auto industry faces challenges from global competition, requiring R&D enhancements and local production incentives for future mobility.

Top News

- Our Sponsors Ad -

Follow us